BillionToOne, Inc.

NASDAQ:BLLN

Medical - Diagnostics & Research

Healthcare
$91.54 +0.84%

+$0.84 today

Market cap
$4.37B
Beta
0.90
P/E (TTM)
182.6
EPS (TTM)
$0.55
52W Low $61.96High $138.70

Volume 1.44M

Average 0.59M

BLLN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

BillionToOne, Inc.NASDAQ: BLLN

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 70.5%

Gross margin was 70.5% in Q2 FY2026, up 5.2 pp from a year earlier. On a trailing-twelve-month basis it was 71.3%, up 10.3 pp year over year.

Context

  • Gross margin widened in 2 of the last 2 fiscal years.
  • FY2025 was the highest level in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
70.5%-2.5 pp QoQ
Last fiscal yearDec 2025
68.3%+15.3 pp YoY
LTMJun 2026
71.3%+10.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.2 pp——
1 year+15.3 pp——
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
68.3%
Year-over-year change
+15.3pp

Gross Margin vs competitors

How BLLN compares with its peers on the latest reported figures

  • BLLN's LTM Jun 2026 gross margin of 71.3% is the 2nd highest of the 9 companies compared; the peer median is 65.2%.
  • Its year-over-year change of +10.3 pp is the 2nd highest of 9, against a peer median of +1.2 pp.
BLLN Competitors Peer median
Gross Margin for BLLN and competitors
Company Period LTM level YoY 3-year change
VCYTVeracyte, Inc.LTM Jun 202672.1% +3.8 pp+3.9 pp
BLLNBillionToOne, Inc.LTM Jun 202671.3% +10.3 pp—
MYGNMyriad Genetics, Inc.LTM Mar 202670.0% -0.0 pp-0.3 pp
WGSGeneDx Holdings Corp.LTM Jun 202668.2% +1.0 pp+81.1 pp
NTRANatera, Inc.LTM Jun 202665.3% +2.4 pp+20.5 pp
GHGuardant Health, Inc.LTM Sep 202665.2% +1.4 pp-0.8 pp
NEONeoGenomics, Inc.LTM Jun 202642.9% -1.0 pp+2.0 pp
FLGTFulgent Genetics, Inc.LTM Mar 202638.7% -0.1 pp-18.7 pp
GRALGRAIL, Inc.LTM Jun 2026-10.8% +45.7 pp+167.1 pp
Peer median (excluding BLLN) 65.2%+1.2 pp+2.9 pp

Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue71.73M152.58M305.11M
Cost of Revenue54.42M71.67M96.65M
Gross Profit17.31M80.92M208.46M
Gross Margin24.1%53.0%68.3%
Research & Development22.41M36.6M49.38M
Selling, General & Admin64.39M91.47M143.05M
Operating Expenses86.8M128.06M192.44M
Depreciation & Amortization6.46M11.69M11.91M
EBITDA(72.94M)(27.47M)19.76M
EBITDA Margin-101.7%-18.0%6.5%
Operating Income(69.5M)(47.15M)16.02M
Operating Margin-96.9%-30.9%5.3%
Interest Income3.46M5.82M7.75M
Interest Expense3.27M2.39M95K
Other Income / Expenses(13.18M)5.61M(8.26M)
Income Before Tax(82.67M)(41.54M)7.76M
Pre-Tax Margin-115.3%-27.2%2.5%
Income Tax Expense9K29K305K
Net Income(82.68M)(41.57M)7.45M
Net Margin-115.3%-27.2%2.4%
EPS (Basic)(1.85)(0.93)0.06
EPS (Diluted)(1.85)(0.93)0.06
Weighted Avg Shares44.72M44.72M45.8M
Weighted Avg Shares (Diluted)44.72M44.72M45.8M

BillionToOne, Inc.

NASDAQ:BLLN

Intrinsic Alpha fair value

Locked

Current Price

$91.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.